Clinica Baviera S.A (CBAV) | Stock Overview & Key Data
Clinica Baviera S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €56.60 on February 6, 2026
Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights
Key Statistics
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Clinica Baviera S.A
CBAV
|
832.96M Mid-cap | -0.38% | 5.69% | 0.00% | 17.65% | 5.48% | 49.86% | 175.86% | 290.98% | 847.18% | 933.80% | 933.80% |
|
Pangaea Oncology
PANG
|
61.77M Small-cap | 1.18% | 1.18% | 2.99% | 1.18% | -0.58% | 3.61% | 17.01% | -25.22% | -31.20% | -31.20% | -31.20% |
|
EuroEspes S.A
EEP
|
6.22M Small-cap | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.85% | -46.53% | -59.70% | -59.70% |
|
Grifols, S.A
GRF
|
6.09B Large-cap | -7.25% | 1.24% | -18.49% | -20.87% | -20.02% | 5.17% | -3.97% | -60.31% | -52.89% | 33.98% | 244.23% |
|
Laboratorios
ROVI
|
4.34B Large-cap | -4.70% | 3.25% | 11.63% | 25.93% | 28.02% | 58.55% | 101.84% | 68.26% | 449.09% | 1,459.62% | 743.04% |
|
Almirall S.A
ALM
|
2.76B Large-cap | -0.47% | 11.78% | -0.16% | 0.79% | -1.40% | 31.68% | 36.63% | -2.60% | -9.40% | 65.19% | -15.31% |
Ownership & Short Interest
Calculate Your Clinica Baviera S.A Investment Returns
Long-Term Investment Performance Analysis
Clinica Baviera S.A stock price in Jul 2016 was €7.13, A €1,000.00 lump sum investment in Clinica Baviera S.A made 9 years ago would be worth approximately €7,293.13 today, representing a exceptional return of 629.31%. This translates to an annualized return (CAGR) of 22.56%.
9 Years 9 Months Investment Scenario (Jul 2016 - Apr 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is CBAV's 52-week high and low?
- In the last 52 weeks, Clinica Baviera S.A reached a high of €56.60 (on February 6, 2026) and a low of €33.70 (on April 24, 2025).
- What is the market cap and P/E ratio for CBAV?
- Curious about Clinica Baviera S.A's size and valuation? Its market capitalization stands at 832.96M. When it comes to valuation, the P/E ratio (trailing twelve months) is 19.77, and the forward P/E (looking ahead) is 29.55.
- Does CBAV pay dividends? If so, what's the yield?
- Yes, Clinica Baviera S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 7.97%, and the company has paid an average of €1.48 per share annually over the past 3 years.
- Who are Clinica Baviera S.A's main competitors or similar companies to consider before investing?
When looking at Clinica Baviera S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Pangaea Oncology
PANG61.77M Healthcare Diagnostics & Research 3.61% 17.01% EuroEspes S.A
EEP6.22M Healthcare Diagnostics & Research 0.00% 0.00% Grifols, S.A
GRF6.09B Healthcare Drug Manufacturers - General 5.17% -3.97% Laboratorios
ROVI4.34B Healthcare Drug Manufacturers - Specialty & Generic 58.55% 101.84% Almirall S.A
ALM2.76B Healthcare Drug Manufacturers - Specialty & Generic 31.68% 36.63% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Clinica Baviera S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Clinica Baviera S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 41.02%, the Debt to Equity ratio from the most recent quarter is 62.33, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for CBAV?
- Looking at Clinica Baviera S.A's growth, its revenue over the trailing twelve months (TTM) was €305M. Compared to the same quarter last year (YoY), quarterly revenue grew by 10.60%, and quarterly earnings saw a YoY growth of 13.00%.
- How much of CBAV stock is held by insiders and institutions?
- Wondering who owns Clinica Baviera S.A stock? Company insiders (like executives and directors) hold about 81.55% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 7.91%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.